Evidence map›Paper›PMID 23792447›Full record

ArticleOncogene2014

Snail1-dependent transcriptional repression of Cezanne2 in hepatocellular carcinoma.

Z Xu, L Pei, L Wang, F Zhang, X Hu, Y Gui

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. OTU deubiquitinases in disease: roles and targeting.Trends in molecular medicine · 2026
    Review
  4. Article
  5. Review
  6. Review
  7. Deubiquitylating Enzymes in Cancer and Immunity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. [Research progress of deubiquitinating enzyme CYLD to regulate liver-related diseases].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2019
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Z XuDepartment of molecular diagnosis, ZhongCheng Translational-Medicine Inc, Shanghai, China.
L PeiDepartment of molecular diagnosis, ZhongCheng Translational-Medicine Inc, Shanghai, China.
L WangSchool of Medicine, Shanghai Jiaotong University, Shanghai, China.
F ZhangDepartment of molecular diagnosis, ZhongCheng Translational-Medicine Inc, Shanghai, China.
X HuSir Run Run Shaw Hospital, Affiliated with School of Medicine, Zhejiang University, Hangzhou, China.
Y GuiSir Run Run Shaw Hospital, Affiliated with School of Medicine, Zhejiang University, Hangzhou, China.
Shanghai Jiao Tong University · CNSir Run Run Shaw Hospital · CNUniversity of Chicago · USZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High malignancy and early metastasis are the hallmarks of hepatocellular carcinoma (HCC). Here, we report that Cezanne2 expression is downregulated in HCC cells and in HCC patients' tumorous tissues and that Cezanne2 is inversely associated with Snail1 expression in HCC patients' tumorous tissues. Chromatin immunoprecipitation assays and the reporter gene assay showed that Snail1 binds to the promoter of the Cezanne2 gene and mediates the direct consequence of Cezanne2 repression. Enhanced expression of Cezanne2 could suppress proliferation, migration and invasion in HCC cells. Further, Cezanne2 could regulate MMP (matrix metalloproteinase)2, MMP9 and ICAM1 (intercellular adhesion molecule) levels through modulation of the NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cell) signaling cascade. Co-immunoprecipitation and in vivo deubiquitination assay indicated that Cezanne2 interacts with TNF receptor-associated factor (TRAF)6 and cleaves the polyubiquitin from TRAF6 substrates. Our data reveal that Snail1-mediated suppression of Cezanne2 may have a key role in HCC malignancy.

Indexed as

Transcription, GeneticAdultAgedCarcinoma, HepatocellularCell Line, TumorCell MovementCell ProliferationDeubiquitinating EnzymesEndopeptidasesFemaleGene Expression Regulation, NeoplasticHumansImmunohistochemistryIntercellular Adhesion Molecule-1Liver NeoplasmsMaleDeubiquitinating EnzymesEndopeptidasesIntercellular Adhesion Molecule-1Matrix Metalloproteinase 2Matrix Metalloproteinase 9NF-kappa BOTUD7A protein, humanSNAI1 protein, humanSnail Family Transcription FactorsTNF Receptor-Associated Factor 6Transcription Factors

Identifiers

PMID23792447
OpenAlexW2071321414

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.